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Abstract
We employed a multivalent peptide-library screening technique to identify a peptide motif
that binds to phosphatidic acid (PA), but not to other phospholipids such as phosphatidyl-
choline (PC), phosphatidylethanolamine (PE), and phosphatidylserine (PS). A tetravalent
peptide with the sequence motif of MARWHRHHH, designated as PAB-TP (phosphatidic
acid-binding tetravalent peptide), was shown to bind as low as 1 mol% of PA in the bilayer
membrane composed of PC and cholesterol. Kinetic analysis of the interaction between
PAB-TP and the membranes containing 10 mol% of PA showed that PAB-TP associated
with PA with a low dissociation constant of KD = 38 ± 5 nM. Coexistence of cholesterol or
PE with PA in the membrane enhanced the PAB-TP binding to PA by increasing the ioniza-
tion of the phosphomonoester head group as well as by changing the microenvironment
of PA molecules in the membrane. Amino acid replacement analysis demonstrated that
the tryptophan residue at position 4 of PAB-TP was involved in the interaction with PA. Fur-
thermore, a series of amino acid substitutions at positions 5 to 9 of PAB-TP revealed the
involvement of consecutive histidine and arginine residues in recognition of the phospho-
monoester head group of PA. Our results demonstrate that the recognition of PA by PAB-
TP is achieved by a combination of hydrophobic, electrostatic and hydrogen-bond interac-
tions, and that the tetravalent structure of PAB-TP contributes to the high affinity binding to
PA in the membrane. The novel PA-binding tetravalent peptide PAB-TP will provide insight
into the molecular mechanism underlying the recognition of PA by PA-binding proteins that
are involved in various cellular events.
Introduction
Phosphatidic acid (PA) is a central intermediate for the synthesis of glycerophospholipids, and
PA produced by the enzymatic activity of phospholipase D plays crucial roles in a variety of cel-
lular functions, such as vesicular trafficking, cytoskeletal organization, cell proliferation and
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signal transduction [1–4]. PA is shown to regulate the function of numerous proteins via direct
binding to its specific binding sites as well as remodeling of the membrane structure by chang-
ing the physicochemical properties in a localized area [5, 6]. The chemical structure of PA con-
sists of a diacylglycerol backbone and an anionic-phosphate head group attached as a
phosphomonoester. The ionization constant of the phosphomonoester of PA displays two pKa
values, a pKa1 of 3.2 and pKa2 of 7.9, in the bilayers composed of phosphatidylcholine (PC),
while pKa2 shifts to 6.9 in the bilayers composed of PC and phosphatidylethanolamine (PE)
[7]. This suggests that under physiological conditions, the ionization properties of PA are quite
sensitive to the organization of lipid molecules in membranes, especially to coexisting lipids
such as PE and cholesterol [7],[8]. Because of its unique ionization properties, PA is also sug-
gested to act as a pH biosensor that coordinately regulates membrane biogenesis and cellular
metabolisms by regulating the binding of the yeast transcription factor Opi1p to membranes in
a pH-dependent manner [9].
More than 50 proteins have been shown to bind to PA in mammalian, plant and yeast cells
[5, 10]. Although the PA-binding domains of protein kinases, protein phosphatases, and tran-
scription factors have been determined, no consensus PA-binding motif was identified among
these proteins, in striking contrast to other lipid-binding domains such as C2, PH, FYVE and
PX that are conserved among various acidic phospholipid-binding proteins [11]. The PA-bind-
ing domains of Opi1p, mammalian Raf-1 kinase, the Rac1 exchange factor DOCK2, and t-
SNARE Spo20p have been well studied: a cluster of basic amino acids have been shown to play
crucial roles in the interaction with PA. These consist of two regions, KRQK and KKR, at resi-
dues 109–112 and 136–138, respectively, of Opi1p [12]; RKTR at residues 398–401 of Raf-1
[13]; three regions, VREM, RPR, and KKR, at residues 1618–1621, 1631–1633 and 1697–1699,
respectively, of DOCK2 [14]; and two regions, KLK and RNK, at residues 66–68 and 71–73,
respectively, of Spo20p [15]. The PA-binding domains of Raf-1, Spo20P and DOCK2 have also
been employed for the generation of biosensors that visualize the distribution of PA in mam-
malian, yeast and plant cells [16, 17]. A recent study of yeast Yas3p, an Opi1 family transcrip-
tion repressor, showed that Yap3P has two regions that bind to PA and phosphoinositides, and
the binding of Yap3p to PA-containing vesicles is significantly enhanced by the presence of PE,
suggesting that the cooperative effects among lipid molecules in biological membranes also
affect the PA-protein interactions [18]. Although the positively charged amino-acid and adja-
cent hydrophobic amino-acid residues of the PA-binding proteins are predicted to form an
amphipathic helix that may be crucial for PA binding, the exact nature of the lipid-protein
interaction remains to be elucidated [19].
We have established various phospholipid-binding probes, including monoclonal antibod-
ies against each of the following: phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) [20], phos-
phatidylserine (PS) [21], phosphatidylcholine (PC) [22]; a tetracyclic peptide of 19 amino acids
(Ro09-0198) that binds specifically to phosphatidylethanolamine (PE) [23]; and the earthworm
protein lysenin that binds specifically to sphingomyelin [24]. These probes have provided use-
ful tools to explore the localization, metabolism, and molecular function of phospholipids [25–
28]. In the present study, we applied the multivalent peptide-library screening technique to
identify a peptide motif that interacts with PA in bilayer membranes. This technique was first
utilized to identify the tetravalent peptide that bound specifically to the globotriaosyl ceramide
(Gb3)-binding sites of Shiga toxin (Stx2) [29]. The library of tetravalent peptides carrying iden-
tical MAXXXXXXX sequence, where X represents a random amino acid residue, was selected
for the binding to the Stx2 B-subunit (2BH) but not to the mutated form of 2BH (2BH-W33A)
lacking the ability to recognize Gb3. Among the four candidate peptides, the tetravalent peptide
with an MAPPPRRRR sequence, designated as PPP-tet, bound to the Gb3-binding sites of Stx2
with extremely high affinity and inhibited the Stx2-mediated bloody diarrhea and hemorrhage
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colitis [30]. The high affinity binding was shown to be partly due to the multivalent interactions
between the PPP-tet and the pentameric B-subunit of Stx2 [29]. The estimated surface area
(~6.3 nm2) covered by the 7 amino acid span of the tetravalent peptide roughly corresponds to
the surface area occupied by 8 ~ 10 molecules of phospholipids in fluid-state membranes [31,
32]. This estimation prompted us to apply the tetravalent peptide-library screening technique
to develop a novel probe that may specifically recognize the molecular structure or a particular
surface distribution of PA molecules in bilayer membranes.
Here we have developed a tetravalent peptide with the sequence motif of MARWHRHHH,
designated as PAB-TP (phosphatidic acid-binding tetravalent peptide), which can bind to as
low as 1 mol% of PA in bilayer membranes. A series of analyses revealed the amino acid resi-
dues responsible for the interaction and the molecular mechanisms underlying the high affinity
peptide-PA interactions in bilayer membranes.
Materials and Methods
Materials
1,2-dioleoyl-sn-glycero-3-phosphate (DOPA), 1,2-dioleoyl-sn-glycero-3-phospho- L-serine
(DOPS), 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DOPG), 1,2-dioleoyl-sn-gly-
cero-3-phospho-(1'-myo-inositol) (DOPI), 1,2-dioleoyl-sn-glycero- 3-phospho-(1'-myo-inositol-
4'-phosphate) (PI(4)P), 1,2-dioleoyl-sn-glycero-3-phospho- (1'-myo-inositol-5'-phosphate)
(PI(5)P), 1,2-dioleoyl-sn-glycero-3-phospho- (1'-myo-inositol-4',5'-bisphosphate) (PI(4,5)P2),
1,2-dioleoyl-sn-glycero-3- phosphocholine (DOPC), 1,2-dimyristoyl-sn-glycero-3-phosphocholine
(DMPC), L-α-phosphatidylcholine (Egg, Chicken) (EggPC), 1,2-dioleoyl-sn-glycero-3- phos-
phoethanolamine (DOPE), N-oleoyl-ceramide-1-phosphate (C1P), 1,2-dioleoyl-sn-glycero-
3-phosphoethanolamine-N- (biotinyl) (biotin-DOPE), and 1,2-dipalmitoyl-sn-glycero-3-phos-
phoethanolamine-N- (cap biotinyl) (biotin-DPPE) were purchased from Avanti Polar Lipids
(Alabaster, AL). Cholesterol and GM3 were obtained fromWako Pure Chemical Industries
(Osaka, Japan) and Matreya LLC (Pleasant Gap, PA), respectively. Tetravalent peptides,
monomer peptides, and the tetravalent peptide library were synthesized using N-α-FMOC-
protected amino acid and standard BOP/HOB coupling chemistry as described previously
[29]. The four peptide-chains present in a given tetravalent peptide were elongated at the
same time from the amino groups of the core polylysine (Fmoc MAP resin; Applied Biosys-
tems, Foster City, CA).
Preparation of large unilamellar vesicle (LUV)
A chloroform solution of lipid mixtures was dried at the bottom of a flask for 15 min and
evaporated in vacuo overnight. The dried lipid film was hydrated with Tris-buffered saline
(TBS; 10 mM Tris-HCl, pH 7.0, 150 mMNaCl). The resulting multilamellar vesicles were put
through five freeze/thaw cycles and then extruded 20 times through a polycarbonate filter with
a pore diameter of 100 nm using an Avanti Mini-Extruder.
Peptide library screening
Screening of the tetravalent peptide libraries was performed as described previously [29]. In
brief, the four peptide-chains present in a given tetravalent peptide (Fig 1A) were elongated
at the same time from the amino groups of the core polylysine. The Met-Ala sequence at the
amino terminus of the library peptides was included to verify that peptides from this mixture
were being sequenced and to qualify the peptides, and the Arg residue at position 6 was fixed
in the library peptides. The predicted degeneracy of a randomize peptide with 6 degenerate
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Fig 1. Identification of PA-binding peptide motif using tetravalent peptide libraries. (A) The tetravalent peptide library was comprised of compounds
with 4 randomized peptides of sequence M1-A2-X3-X4-X5-R6-X7-X8-X9-AU (U; amino hexanoic acid), where X at positions 3–5 and 7–9 indicates any amino
acids except cysteine. Screening of the library was performed to identify compounds that bound to vesicles containing PA but not to vesicles without PA.
Sequences of PA binding peptides (peptide 1 to 4) were determined by comparing relative abundance of amino acids in each degenerate position of PA-,
PC-, and PS-bound peptides. (B) Binding of the tetravalent peptides to LUVs composed of DOPA/DOPC/biotin-DOPE/cholesterol (10:58:2:30) was
examined by the SPVB assay (mean ± SE, n = 3). The binding of LUVs at the concentration of 125 μM to peptide 3 was represented as 100 (arbitrary units).
doi:10.1371/journal.pone.0131668.g001
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positions is 196 (47 million). LUVs composed of either DOPA/DMPC/biotin-DOPE/choles-
terol (10:38:2:50), DMPC/biotin-DOPE/cholesterol (48:2:50) or DOPS/DMPC/biotin-DOPE/
cholesterol (10:38:2:50) were incubated with Streptavidin-Agarose beads from Sigma Aldrich
(St. Louis, MO) and washed with PBS. Vesicles containing DMPC were used for screening to
avoid disruption of the membrane integrity during incubation with the library peptides and
washing procedures. The LUVs bound to the beads were incubated with the library peptides
for 16 h at 4°C. After washing with PBS, peptides bound to the LUVs were separated by
SDS-PAGE and sequenced on an Applied Biosystems model 477A protein sequencer. To calcu-
late the relative amino acid preference at each degenerate position, the corrected quantities of
amino acids were compared with those obtained using LUVs of different phospholipid compo-
sitions. The relative abundance of individual amino acids at the degenerate positions reflects
the relative abundance of high-affinity peptides containing these amino acids [29].
Solid phase vesicle-binding (SPVB) assay
96-well microtiter plates (Greiner Bio-One GmbH, Kremsmünster, Austria) were coated with
50 μL of PAB-TP (10 μg/mL) in TBS. After blocking with TBS containing 3% bovine serum
albumin (BSA), PAB-TP coated on the solid phase was incubated with various concentrations
of LUVs containing 2 mol% of biotin-DOPE (details of composition are described in figure leg-
ends) in TBS containing 1% BSA for 1 h at room temperature. After washing with TBS, the
wells were incubated with HRP-conjugated streptavidin diluted 1/1000 with TBS containing
1% BSA for 45 min. The intensity of the color developed with o-phenylenediamine as the sub-
strate for 3 to 20 min was measured using an Infinite F200 PRO microplate reader (TECAN).
Appropriate reaction time for the color development, which was constant in individual curves
of each Figure, was employed to avoid the saturation of peroxidase reaction.
Fluorescence measurement
Fluorescence measurements were carried out using an LS55 Fluorescence Spectrometer (Perkin
Elmer). 10 μg/ml (1.6 μM) of PAB-TP was incubated with LUVs (0–160 μM) in TBS for 1 h at
25°C. Tryptophan emission fluorescence was recorded at 25°C from 300 to 420 nm using a 280
nm excitation wavelength [33].
Quartz crystal microbalance with dissipation (QCM-D) measurement
QCM-D measurement was performed by using a Q-Sense E1 (Q-sense, Göteborg, Sweden) as
described previously [34]. The sensor coated with SiO2 (QSX303; Q-sense) was cleaned in 2%
SDS solution (30 min at 50°C), rinsed with Milli-Q water, dried under a N2 stream and treated
with UV-ozone cleaner (PC450; Meiwafosis, Japan). The sensor was oscillated at the resonance
frequency of 5 MHz and at 6 overtone harmonics (15, 25, 35, 45, 55 and 65 MHz). The differ-
ence of frequency (Δf) and dissipation (ΔD) were recorded. The 25, 35, 45 and 55 MHz har-
monics were used for the analysis.
The sensor was equilibrated with TBS before measurement. The solution was subsequently
flowed onto the sensor surface. A supported lipid bilayer (SLB) was formed on the sensor sur-
face by flowing small unilamellar vesicles (SUVs) (0.2 mM total lipids) composed of EggPC/
biotin-DPPE (99:1). After the surface was rinsed with TBS to remove excess SUVs, 2 μM strep-
tavidin was introduced to be fixed on the lipid membrane. The streptavidin layer was rinsed
with TBS and then LUVs (0.2 mM total lipids) composed of DOPA/DOPC/biotin-DOPE/cho-
lesterol (10:58:2:30) or DOPC/biotin-DOPE/cholesterol (68:2:30) were introduced. To deter-
mine the interaction between PAB-TP and LUVs, increasing concentrations of PAB-TP (7.8–
1000 nM) were introduced onto the LUV layer to induce the binding. Between the flows of
A Tetravalent Phosphatidic Acid-Binding Peptide
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PAB-TP, TBS was introduced to induce the release of PAB-TP. KD, koff, and kon were calculated
from the profile of PAB-TP binding and release.
Vesicle size and zeta potential measurement
The particle sizes and zeta potentials of vesicles were determined at 25°C using a Zetasizer
Nano ZS (Malvern Instruments Ltd., UK) [35]. The concentration of the sample was kept con-
stant at 1.0 mM.
Results and Discussion
Identification of a tetravalent peptide that binds to PA
In this study, we employed a peptide library composed of tetravalent peptides containing a
polylysine core bifurcating at both ends with six randomized residues and fixed methionine,
alanine, and arginine at positions, 1, 2, and 6, respectively [29] (Fig 1A). The peptide library
was screened for its ability to bind to vesicles containing PA but not to vesicles without PA. As
previously reported for screening of the Stx2-binding peptide [29], we determined the relative
amino acid preference at each position, and identified four candidate sequence motifs:
MAKKMRRRM, MAKHRRTWY, MARWHRHHH, and MAMWHRTWR (Fig 1A). The tet-
ravalent forms of these peptides with the same core structure were synthesized and were evalu-
ated for their ability to bind to vesicles containing PA by the solid phase vesicle-binding
(SPVB) assay. In this assay, the peptides coated on the solid phase were incubated with LUVs
composed of DOPA, DOPC, biotin-DOPE, and cholesterol at the molar ratio of 10:58:2:30, fol-
lowed by quantification of the binding of vesicle to the peptide using HRP-streptavidin. As
shown in Fig 1B, the tetravalent peptide 3 with the sequence motif of MARWHRHHH bound
effectively to the PA-containing vesicle, while only weak or no significant bindings were
observed with other peptides. We designated the tetravalent peptide 3 with the sequence of
MARWHRHHH as PAB-TP (phosphatidic acid-binding tetravalent peptide) and employed it
for further analyses. In the SPVB assay, PAB-TP did not bind to the vesicles without PA, but
bound effectively to the vesicles containing as low as 1 mol% of PA (Fig 2A). PAB-TP did not
bind to the vesicles containing PE, PG, or ganglioside GM3, but exhibited a weak cross-reactiv-
ity with vesicles containing PS or PI (Fig 2B).
Our attempts to perform a kinetic analysis of the interaction between PAB-TP and PA-con-
taining membranes using surface plasmon resonance measurement were hampered by non-
specific adhesion of the peptide to sensor chips. To overcome this problem, we employed the
quartz crystal microbalance (QCM) method, and coated the sensor chips with multiple mem-
brane layers to suppress the non-specific adhesion of the peptide. The kinetic analyses showed
that PAB-TP was associated with a membrane surface containing 10 mol% of PA with a kon
value of 5.2 ± 0.1 x 103 M-1 s-1 and koff value of 2.0 ± 0.3 x 10
−4 s-1, giving a very low dissocia-
tion constant of KD = 38 ± 5 nM (S1 Fig). The kinetic parameters for the binding of PAB-TP to
membranes composed of PC and cholesterol were as follows: kon 5.5 ± 0.0 x 10
3 M-1 s-1, koff
3.2 ± 0.2 x 10−3 s-1, and KD 0.58 ± 0.03 μM.
Effect of PE and cholesterol on the binding of PAB-TP to PA-containing
vesicles
Since Kooijman et al. have shown that the ionization of PA is enhanced by coexistence of PE
and cholesterol [7], we next analyzed the effect of PE and cholesterol on the binding of
PAB-TP to PA. As shown in Fig 3A, the PAB-TP binding to PA in the PC membranes was sig-
nificantly enhanced by the presence of PE. The coexistence of cholesterol also drastically
A Tetravalent Phosphatidic Acid-Binding Peptide
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Fig 2. Analysis of binding of PAB-TP to phospholipids by the solid phase vesicle-binding assay. (A) Binding of PAB-TP to LUVs composed of DOPA/
DOPC/biotin-DOPE/cholesterol (10:58:2:30), (5:63:2:30), (2:66:2:30), (1:67:2:30), and (0:68:2:30) was examined by the SPVB assay (mean ± SE, n = 3). (B)
Binding of PAB-TP to LUVs composed of DOPC, biotin-DOPE, cholesterol, and indicated lipid (58:2:30:10) was examined by the SPVB assay (mean ±SE,
n = 3). (A, B) The binding of LUVs composed of DOPA/DOPC/biotin-DOPE/cholesterol (10:58:2:30) at the concentration of 125 μM to PAB-TP was
represented as 100 (arbitrary units).
doi:10.1371/journal.pone.0131668.g002
A Tetravalent Phosphatidic Acid-Binding Peptide
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Fig 3. Effect of PE and cholesterol on the binding of PAB-TP to PA-containing vesicles. (A) Binding of PAB-TP to LUVs composed of DOPA/DOPC/
biotin-DOPE/DOPE (10:88:2:0), (10:78:2:10), (10:58:2:30), and (10:38:2:50) was examined by the SPVB assay (mean ± SE, n = 3). (B) Binding of PAB-TP to
LUVs composed of DOPA/DOPC/biotin-DOPE/cholesterol (10:88:2:0), (10:78:2:10), (10:58:2:30), and (10:38:2:50) was examined by the SPVB assay
(mean ± SE, n = 3). (A, B) The binding of LUVs composed of DOPA/DOPC/biotin-DOPE (10:88:2) at the concentration of 125 μM to PAB-TP was
represented as 100 (arbitrary units).
doi:10.1371/journal.pone.0131668.g003
A Tetravalent Phosphatidic Acid-Binding Peptide
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increased the binding of PAB-TP to the PA-containing vesicles (Fig 3B). To examine the effect
of PE and cholesterol on the electrostatic properties of the membranes, we measured the zeta
potential of the PA-containing vesicles with various amounts of PE and cholesterol. A signifi-
cant increase in the negative zeta potential was observed with the presence of PE in the PA-
containing vesicles (Table 1), reflecting the formation of a hydrogen bond between PE and
phosphomonoester of PA that causes further deprotonation and ionization of PA [7]. The neg-
ative zeta potential of the PA-containing vesicles was also remarkably increased in a dose-
dependent manner by cholesterol (Table 1). Addition of cholesterol into the vesicles in the
absence of PA did not significantly affect the zeta potential (-0.4±0.4 and -1.7±0.4 mV for vesi-
cles composed of only DOPC and DOPC/cholesterol (50:50), respectively), indicating that the
effect of cholesterol reflects the increased ionization of PA. Furthermore, the size of the PA-
containing vesicle was not significantly affected by the presence of PE or cholesterol (Table 1).
These results suggest that the presence of PE or cholesterol increases the negative surface
charge of the PA-containing vesicles, causing the enhanced binding of PAB-TP to the mem-
brane. Although PE and cholesterol caused the comparable increase in the negative zeta poten-
tial, cholesterol has a more striking effect on the binding of PAB-TP to the PA-containing
vesicles. As proposed by Kooijman et al. it is likely that cholesterol has additional effects such
as induction of negative curvature stress in the planar lipid bilayers that enhance the insertion
of hydrophobic residues into the hydrophobic interior of lipid bilayer [7]. Taken together,
these results suggest that PAB-TP can distinguish the cholesterol and PE-mediated changes in
the ionization properties of PA molecules as well as the microenvironment of PA molecules
such as curvature stress of the lipid bilayer.
Inhibition analysis of SPVB assay
The interaction between PAB-TP with the water-soluble head group of PA and other soluble
compounds carrying the phosphomonoester group was examined by inhibition analysis of the
SPVB assay. LUV composed of PA effectively inhibited the binding of PA-containing vesicles
to PAB-TP, but no significant inhibition was observed with soluble compounds such as glyc-
erol 3-phosphate and ATP (Fig 4A). This result suggests that a secondary interaction between
PAB-TP and the hydrophobic fatty acyl chains of the PA molecules is required for the stable
complex formation. The presence of divalent cations such as Cu2+, Zn2+, Ni2+, and Co2+ that
associate with histidine also effectively inhibited the binding, while neither Ca2+ nor Mg2+ had
a significant effect on the binding, suggesting that the histidine residues of PAB-TP may play a
critical role in the binding to PA (Fig 4B).
Table 1. Zeta potential and size of LUVs.
Lipid composition (mol%)
DOPA DOPC cholesterol DOPE Zeta potential (mV) Vesicle size (nm)
10 90 0 0 -5.6 ± 0.8 111.1 ± 0.5
10 80 10 0 -9.7 ± 0.4 166.6 ± 1.6
10 60 30 0 -10.9 ± 0.7 147.7 ± 8.2
10 40 50 0 -16.3 ± 0.0 130.8 ± 1.7
10 80 0 10 -8.7 ± 0.8 124.9 ± 0.8
10 60 0 30 -8.0 ± 1.0 126.2 ± 0.8
10 40 0 50 -11.5 ± 0.3 126.0 ± 0.6
Zeta potential (mV) and vesicle size of LUVs composed of indicated lipids were determined using a Zetasizer Nano ZS (mean ± SE, n = 3).
doi:10.1371/journal.pone.0131668.t001
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Fig 4. Inhibitory effect of soluble head groups and divalent cations on binding of PAB-TP to vesicles containing PA. (A) Binding of PAB-TP to LUVs
(31.25 μM total lipids) composed of DOPA/DOPC/biotin-DOPE/cholesterol (10:58:2:30) in the presence of indicated concentrations of ATP, glycerol
3-phosphate, phosphate, and LUVs composed of DOPA was examined by the SPVB assay. (mean ± SE, n = 3). (B) PAB-TP coated on the solid phase was
incubated with MgCl2, CaCl2, CoCl2, NiCl2, ZnCl2, and CuCl2 (0.1, 1, 10 mM). After removal of unbound divalent cations, binding of PAB-TP to LUVs
(31.25 μM total lipids) composed of DOPA/DOPC/biotin-DOPE/cholesterol (10:58:2:30) was examined by the SPVB assay. (mean ± SE, n = 3). The binding
of LUVs to PAB-TP in the absence of competitor (A) or divalent cation (B) was represented as 100 (arbitrary units).
doi:10.1371/journal.pone.0131668.g004
A Tetravalent Phosphatidic Acid-Binding Peptide
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Amino acid residues involved in the PA-binding
To evaluate the possible involvement of each amino acid residue in the binding, the effect of
alanine replacement of PAB-TP on its binding to PA-containing vesicles was examined. Ala-
nine replacement of the Trp residue at position 4 significantly reduced the binding, while no
significant change in the binding was observed with the replacement of other residues (Fig 5A).
Since the binding was not significantly affected by the alanine replacements of a single His or
Arg residue, we next examined the binding of double replacement mutants to PA-containing
vesicles. As shown in Fig 5B, double replacement of the consecutive His and Arg residues (H5/
R6 and R6/H7) significantly diminished the binding, while those of His residues (H5/H7) had
no significant effect. Triple replacement of either H5/R6/H7 or R6/H7/H8 also strongly
affected the binding. The wavelength of maximum fluorescence of triple replacement mutants
(excitation 280 nm) in the absence of lipids is comparable to that of PAB-TP, indicating that
abolishment of binding properties in triple replacement mutants was not due to the self-segre-
gation of the peptide chains (data not shown) (see below). These results suggest that the Trp
residue and the couplings of consecutive Arg and His residues play a critical role in the associa-
tion of TAB-TP to the PA molecules in the membrane.
Fluorescence analysis of phospholipid specificity
Fluorescence of Trp is highly sensitive to the local environment; in particular, the emission
maximum (λmax) of a Trp residue is dependent on its interaction with the membrane bilayer
[33, 36]. When PAB-TP was incubated with LUVs composed of DOPA, DOPC, and choles-
terol at the molar ratio of 10:60:30, an extensive blue shift in the Trp emission spectra of
PAB-TP was observed, while no significant shift was observed upon incubation with the vesi-
cles without PA (Fig 6A). A progressive shift of λmax to shorter wavelength was observed in a
dose-dependent manner of the PA-containing vesicles, while no significant shift was seen even
with the highest concentration of the vesicles without PA (Fig 6B). Together with the results
obtained by the inhibition analysis of SPVB assay (Fig 4A) and the amino acid replacement
analysis (Fig 5A), these results indicate that the interaction with the hydrophobic interior of
the lipid bilayer is responsible for the stable association of PAB-TP to the membrane. We next
reevaluated the interaction between the soluble form of PAB-TP and PA-containing vesicles by
measuring the shift in the Trp emission spectra. As shown in Fig 7A, the shift of λmax was
highly dependent on the contents of PA in the membrane, which was consistent with the
results obtained with the SPVB assay (Fig 2A). Analysis of the phospholipid specificity of
PAB-TP in the fluorescence shift assay demonstrated that the peptide showed a weak cross-
reaction with PS, ceramide-1-phosphate (C1P), PG, and GM3, but a significant cross-reactivity
with PI(4,5)P2 was observed (Fig 7B). Quantitative analysis showed that PAB-TP cross-reacted
with PI(5)P, PI(4)P and PI(4,5)P2 to the same extent as with PA, suggesting that the phospho-
monoester head group of phospholipids is required for the high affinity interaction with
PAB-TP (Fig 7C). It is noteworthy that PAB-TP exhibited differential reactivity to the phos-
phomonoester-containing phospholipids, i.e. PA and C1P, implying that the structural or
physicochemical properties of C1P might affect the interaction with PAB-TP [37].
In summary, we have established a novel tetravalent peptide PAB-TP that can react with as
low as 1 mol% of PA and distinguish the ionization properties and the microenvironment of
PA molecules in the membrane. The key features that confer the high affinity binding to PA
are the involvement of the Trp residue and the couplings of adjacent Arg and His residues in
the binding as well as their multivalent interactions with PA molecules dispersed in the mem-
brane. The Trp residue at position 4 (Fig 1A) was shown to be involved in the interaction with
PA by the amino acid replacement analysis (Fig 5A). Although the contribution of a single Arg
A Tetravalent Phosphatidic Acid-Binding Peptide
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Fig 5. Identification of amino acid residues involved in the PA-binding. (A, B) Binding of alanine mutants
of PAB-TP to LUVs (125 μM total lipids) composed of DOPA/DOPC/biotin-DOPE/cholesterol (10:58:2:30)
was examined by the SPVB assay. Substituted amino acids were indicated by outline characters.
(mean ± SE, n = 3). The binding of LUVs to PAB-TP (MARWHRHHH) was represented as 100 (arbitrary
units).
doi:10.1371/journal.pone.0131668.g005
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Fig 6. Fluorescencemeasurement of tryptophan residues. (A) PAB-TP was incubated with or without LUVs (160 μM total lipids) composed of DOPA/
DOPC/cholesterol (10:60:30) and DOPC/cholesterol (70:30) for 1h at 25°C. Fluorescence spectra were obtained with the excitation wavelength at 280 nm.
(B) PAB-TP was incubated with LUVs (0–160 μM total lipids) composed of DOPA/DOPC/cholesterol (10:60:30) and DOPC/cholesterol (70:30) for 1h at
25°C. Fluorescence spectra were obtained with the excitation wavelength at 280 nm and the wavelength of maximum fluorescence (λmax) was plotted
against the molar ratio of lipid to peptide. (mean ± SE, n = 3).
doi:10.1371/journal.pone.0131668.g006
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Fig 7. Analysis of PAB-TP by fluorescence measurement of tryptophan residues. (A) PAB-TP was incubated with LUVs (160 μM total lipids) composed
of DOPA/DOPC/cholesterol (10:60:30), (5:65:30), (2:68:30), (1:69:30), and (0:70:30) for 1h at 25°C. Fluorescence spectra were obtained with the excitation
wavelength at 280 nm and the wavelength of maximum fluorescence (λmax) was plotted against PA content (mol%). (mean ± SE, n = 3). (B) PAB-TP was
incubated with LUVs (160 μM total lipids) composed of DOPC, cholesterol, and indicated lipids (60:30:10) for 1h at 25°C. Fluorescence spectra were
obtained with the excitation wavelength at 280 nm and blue shift in the wavelength of maximum fluorescence (λmax) was calculated. (mean ± SE, n = 3). (C)
PAB-TP was incubated with LUVs (0–160 μM total lipids) composed of DOPC, cholesterol, and indicated phospholipid (60:30:10) for 1h at 25°C.
A Tetravalent Phosphatidic Acid-Binding Peptide
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or His residue is relatively small (Fig 5A), the couplings of adjacent Arg and His residues at
positions from 5 to 7 are required for the effective binding (Fig 5B). It is noteworthy here that,
Kooijman et al. demonstrated that the hydrogen-bond formation between the phosphate of PA
and amino acid residues such as lysine and arginine in proteins increased the charge of PA,
thereby stabilizing the protein-lipid interaction [38]. Involvement of His residues in the inter-
action with the phosphate of phospholipids has been observed with various enzymes such as
phospholipase A2 [39] and phospholipase D [40]; a recent study on the crystal structure of E.
coli phosphatidylglycerol-phosphatase B (ecPgpB), a membrane-integrated type II PA phos-
phatase (PAP2) that catalyzes the dephosphorylation of PA, showed that two His and two Arg
residues are involved in the putative phosphate-binding site [41]. The mutations in these resi-
dues abolish the catalytic activity of ecPgpB, and these residues are conserved among members
of the PAP2 family. With these observations, it is plausible to speculate that a combination of
electrostatic and hydrogen bond interactions mediated by the adjacent His and Arg residues
with the phosphomonoester head group of PA provide the basis of the high-affinity interaction
of PAB-TP with PA as originally proposed for PA-binding proteins by Kooijman [38].
PAB-TP may provide a useful tool to observe the intracellular and transbilayer distribution
of PA by using a freeze-fracture replica labeling immunoelectron microscopy [42]. However,
further structural analyses to increase the specificity for PA and labeling of the peptide without
changing the reactivity of the peptide are required to explore the molecular motion and func-
tion of PA in living cell membrane
Supporting Information
S1 Fig. Kinetic analysis of binding of PAB-TP to PA-containing vesicles by QCM-Dmea-
surements. LUV layers composed of DOPA/DOPC/biotin-DOPE/cholesterol (10:58:2:30) or
DOPC/biotin-DOPE/cholesterol (68:2:30) was incubated with increasing concentrations of
PAB-TP ((i) 7.8, (ii) 16, (iii) 63, (iv) 125, (v) 250, (vi) 500, (vii) 1000 nM) for 5 min. After incu-
bation with each concentration of PAB-TP, TBS was introduced to induce the release of
PAB-TP for 5 min. Representative result at 35 MHz harmonic was shown.
(TIF)
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